# A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea

> **NCT01234168** · — · COMPLETED · sponsor: **Ipsen** · enrollment: 340 (actual)

## Conditions studied

- Neuroendocrine Tumors
- Carcinoid Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01234168
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 340 (ACTUAL)
- **Last updated:** 2020-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01234168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01234168, "A Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01234168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*